查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
ELISA 診斷測試市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按採用情況、測試類型、應用、最終用戶和地理位置
市場調查報告書
商品編碼
1389672

ELISA 診斷測試市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按採用情況、測試類型、應用、最終用戶和地理位置

ELISA Diagnostic Test Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption, Test Type, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 199 Pages | 訂單完成後即時交付

價格

ELISA診斷測試市場預計將從2022年的12.8549億美元成長到2030年的22.7123億美元；預計2022年至2030年CAGR為7.37%。市場發展的主要促進因素是動物傳染病的增加，而人類感染發生率的增加是市場發展的主要促進因素。

酵素連結免疫吸附測定法 (ELISA) 是一種檢測和測量患者血液中抗體的測試。此測試可用於確定患者是否具有與某些傳染病相關的抗體。 ELISA 檢測用於診斷愛滋病毒、萊姆病、惡性貧血、輪狀病毒等。 ELISA 試劑盒是一種有價值的研究工具，可快速、方便、精確地檢測和定量樣本和培養物中的特定標靶。市售 ELISA 試劑盒配有預包被板、捕獲/檢測抗體、標準品、緩衝液和其他必要的試劑。每個試劑盒都經過嚴格的驗證和穩定性測試，以確保準確性、精密度、靈敏度、特異性和重現性。

創新產品的推出為 ELISA 診斷測試市場創造了機會。

ELISA 因其靈活性、靈敏度和易於使用等多種優點而成為最受歡迎的免疫分析測試之一。此外，ELISA 檢測試劑盒的低成本以及與高通量檢測相關的多方面適用性使其成為滿足各種研究和 IVD 要求的理想解決方案。憑藉低成本的適用性，檢測試劑盒的產品創新增強了對人類和動物研究的需求。此外，製造商也專注於利用內部設施開發 ELISA 檢測試劑盒。

Innovative Research 公司銷售多種 ELISA 試劑盒，可選擇性地辨識多種凝血劑、物種和抗體。 「Human Factor IX Kit」就是 Innovative Research 生產的一個這樣的例子。人類凝血因子 IX 抗原測定旨在定量測定人類血漿中總因子 IX 抗原。此試劑盒建議僅用於研究目的，試劑最多可用於 96 項臨床測試。

此外，在 COVID-19 大流行期間，製造商推出了 ELISA 測試的創新產品，加速了 ELISA 測試在人類中的採用。

2022 年 12 月，Pictor Limited 宣布推出「PictArray SARS-CoV-2 抗體測試」新產品，該產品已展示了針對患者和醫生的真正臨床實用性。新產品可檢測與 COVID-19 病毒相關的感染，產生的臨床結果可幫助患者和醫生治療和管理 SARS-CoV-2 感染。製造商推出的創新 ELISA 檢測試劑盒有望以低成本和多方面的應用為診斷與不同類型物種相關的各種感染提供有效的臨床結果。因此，從長遠來看，創新產品的推出將為製造商提供利潤豐厚的機會。

市場趨勢

基於 ELISA 的程序的進展

ELISA 在體外診斷 (IVD) 中的應用在全球市場上引起了相當大的關注。透過磁珠、紙基平台和奈米材料等技術，基於 ELISA 的程序的開發和應用吸引了來自各個領域的研究人員。基於技術的 ELISA 試劑盒的其他範例包括數位 ELISA、多重 ELISA、單分子 ELISA、基於奈米顆粒的 ELISA 和基於智慧型手機的 ELISA。此外，該公司還推出基於多種技術的 ELISA 檢測試劑盒，以實現快速有效的臨床結果。 「AMP'D ELISA 訊號放大系統」由 Enzo Life Sciences, Inc. 製造。AMP'D 技術透過單一放大套件有效提高了夾心 ELISA 測試類型的靈敏度，並提供高靈敏度。

Cell Signaling Technology, Inc. 的「PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit」由 Cell Signaling Technology 設計，是技術先進的 ELISA 檢測試劑盒產品的另一個例子。這種基於先進技術的 ELISA 檢測試劑盒產品未來將受到獸醫的高度需求，用於檢測導致獸醫和​​人類相關感染或疾病的不同物種。因此，基於 ELISA 的程序的進步預計將促進 2020-2030 年 ELISA 診斷測試市場的成長。

基於應用程式的見解

從應用來看，ELISA診斷測試市場分為自體免疫疾病、傳染病、癌症診斷、蛋白質定量等。傳染病細分市場在2022年佔據最大市場佔有率，預計2022-2030年市場CAGR最高，達8.43%。 ELISA 是免疫學中一種強大的技術，用於檢測抗體和抗原以及進行過敏測試和自體免疫疾病診斷。由於人口老化以及人口結構和生活方式的變化，全球自體免疫疾病和病毒性疾病（HIV、STI、B型肝炎等）的發病率不斷上升，推動了全球 ELISA 診斷測試市場的成長。根據美國國家幹細胞基金會2023年的統計，自體免疫疾病影響80多種不同類型的疾病，影響全球近4%的人口。最常見的自體免疫疾病包括第 1 型糖尿病、多發性硬化症、類風濕性關節炎、紅斑性狼瘡、克隆氏症、牛皮癬和硬皮症。在美國，自體免疫疾病是慢性病的第三大常見原因。儘管這些疾病很少見，但總體而言，這些疾病影響著 5% 至 8% 的美國人口。例如，根據 PubMed Central 於 2022 年 5 月發表的一篇文章，自體免疫性大皰病 (AIBD) 特異性抗體的傳統血清學檢測涉及使用組織基質進行初步篩選，然後進行 ELISA 等抗原特異性測定。

此外，各種技術進步，例如下一代免疫診斷平台的開發，預計將推動市場成長。

根據測試類型，可分為夾心 ELISA、間接 ELISA、競爭性 ELISA 以及多重攜帶式 ELISA。間接 ELISA 細分市場在 2022 年佔據更大的市場佔有率，預計該細分市場在 2022-2030 年期間將實現更高的CAGR。

ELISA 診斷測試市場按最終用戶分類，分為醫院和診斷中心、製藥和生物技術公司、獸醫醫院和診斷實驗室等。 2020-2030 年，醫院和診斷中心細分市場佔據最大市場。

目錄

第 1 章：簡介

  • Insight Partners 研究報告指南
  • 市場區隔
    • 全球 ELISA 診斷測試市場 - 按採用分類
    • 全球 ELISA 診斷測試市場 - 按測試類型
    • 全球 ELISA 診斷測試市場 - 按應用
    • 全球 ELISA 診斷測試市場 - 按最終用戶分類
    • 全球 ELISA 診斷測試市場 - 按地區

第 2 章：執行摘要

  • 重要見解
  • ELISA 診斷測試市場（按地域）

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：ELISA 診斷測試市場格局

  • 概述
  • PEST分析
    • PEST分析

第 5 章：ELISA 診斷測試市場 - 主要產業動態

  • 主要市場促進因素
    • 動物傳染病不斷增加
    • 人類感染發生率增加
  • 主要市場限制
    • 產品召回事件
  • 主要市場機會
    • 創新產品發布
  • 未來的趨勢
    • 基於 ELISA 的程序的進展

第 6 章：ELISA 診斷測試市場 - 全球市場分析

  • ELISA 診斷測試市場收入，2022 - 2030

第 7 章：全球 ELISA 診斷測試市場 - 收入和 2030 年預測 - 按採用情況

  • 概述
  • 2022 年及 2030 年 ELISA 診斷測試市場收入佔有率，依採用情況分類 (%)
  • 人類
  • 獸醫

第 8 章：全球 ELISA 診斷測試市場 - 收入和 2030 年預測 - 按測試類型

  • 概述
  • 2022 年和 2030 年 ELISA 診斷測試市場收入佔有率，按測試類型分類 (%)
  • 夾心ELISA
  • 間接ELISA
  • 競爭性ELISA
  • 多重攜帶式 ELISA

第 9 章：全球 ELISA 診斷測試市場 - 收入和 2030 年預測 -按應用

  • 概述
  • 2022 年和 2030 年 ELISA 診斷測試市場收入佔有率，按應用分類 (%)
  • 自體免疫疾病
  • 傳染病
  • 癌症診斷
  • 蛋白質定量
  • 其他

第 10 章：全球 ELISA 診斷測試市場 - 收入和 2030 年預測 - 按最終用戶

  • 概述
  • 2022 年和 2030 年 ELISA 診斷測試市場收入佔有率（按最終用戶分類）（%）
  • 醫院和診斷中心
  • 製藥與生物技術公司
  • 獸醫醫院和診斷實驗室
  • 其他

第 11 章：ELISA 診斷測試市場 - 2030 年收入和預測 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第 12 章：ELISA 診斷測試市場-產業格局

  • 概述
  • ELISA 診斷測試市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 13 章：公司簡介

  • Bio-Rad Laboratories Inc
  • Idexx Laboratories Inc
  • F. Hoffmann-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Abbott Laboratories
  • Danaher Corp
  • Innovative Diagnostics SAS
  • Pictor Ltd
  • DiaSorin SpA
  • Elabscience Biotechnology Inc
  • Bio-Techne Corp

第 14 章：附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00030120

The ELISA Diagnostic Test Market is expected to grow from US$ 1,285.49 million in 2022 to US$ 2,271.23 million by 2030; it is estimated to register a CAGR of 7.37% from 2022 to 2030. Key driving factors behind the market development are the rising infectious diseases among animals and the increasing incidence of human infections are the key driving factors behind the market development.

An enzyme-linked immunosorbent assay (ELISA) is a test that detects and measures antibodies in a patient's blood. This test can be used to determine if the patient has antibodies related to certain infectious conditions. An ELISA test is used to diagnose HIV causing AIDS, Lyme disease, pernicious anemia, rotavirus, and among others. ELISA kits are a valuable research tool that offer quick, convenient, and precise detection and quantitation of specific targets in samples and cultures. Commercially available ELISA kits come with pre-coated plates, capture/detection antibodies, standards, buffers, and other necessary reagents. Each kit undergoes rigorous validation and stability testing to ensure accuracy, precision, sensitivity, specificity, and reproducibility.

Innovative Product Launches Creates Opportunities in ELISA Diagnostic Test Market.

ELISA is one of the most popular immunoassay tests owing to its various advantages such as flexibility, sensitivity, and easy-to-use features. Also, low cost of ELISA test kit and multifaceted applicability associated with high-throughput testing make it an ideal solution for various research and IVD requirements. With low-cost applicability, product innovations in the test kits enhance the demand for human and animal research. Also, manufacturers focus on developing ELISA test kits with in-house facilities.

Innovative Research company sells a wide range of ELISA kits with selectivity to a broad range in identifying coagulants, species, and antibodies. "Human Factor IX Kit" is one such example manufactured by Innovative Research. The human coagulation Factor IX antigen assay is intended for the quantitative determination of total Factor IX antigen in human plasma. The kit is recommended to use only for research purposes, and reagents can be utilized for up to 96 clinical tests.

Additionally, innovative product launches for ELISA tests by the manufacturers amid the COVID-19 pandemic accelerate the adoption of ELISA testing among humans.

In December 2022, Pictor Limited announced a new product launch of the "PictArray SARS-CoV-2 Antibody Test," which has demonstrated real clinical utility intended for patients and doctors. The new product detects the infection associated with the COVID-19 virus, and the clinical results produced assist the patients and doctors in treating and managing SARS-CoV-2 infection. Launches of innovative ELISA test kits by manufacturers are expected to provide effective clinical results for diagnosing varied infections associated with different types of species with low cost and multifaceted applications. Thus, innovative product launches would provide lucrative opportunities for manufacturers in the long run.

Market Trend

Advancements in ELISA-Based Procedures

The use of ELISA for in-vitro diagnostics (IVD) has gained considerable attention in the global market. Researchers from various fields have been attracted to the development and application of ELISA-based procedures through techniques such as magnetic beads, paper-based platforms, and nanomaterials. Other examples of technology-based ELISA kits are digital ELISA, Multiplex ELISA, Single-Molecule ELISA, Nanoparticle-Based ELISA, and Smartphone-Based ELISA. Also, companies launch ELISA testing kits based on several techniques for fast and efficient clinical results. The "AMP'D ELISA Signal Amplification system" is manufactured by Enzo Life Sciences, Inc. The AMP'D Technology efficiently improves the sensitivity of sandwich ELISA test type with a single amplification kit and offers high sensitivity.

Cell Signaling Technology, Inc.'s "PathScan Phospho-RSK1 (Ser380) Sandwich ELISA Kit," designed by Cell Signaling Technology, is another example of a technology-advanced ELISA test kit product. Such advanced technology-based ELISA test kit products will have a high demand in the future by veterinarians for the detection of different species responsible for veterinary and human-associated infections or diseases. Therefore, advancements in ELISA-based procedures are expected to bolster the ELISA diagnostic test market growth during 2020-2030.

Application-Based Insights

In terms of Application, the ELISA Diagnosis Test Market is categorized into autoimmune diseases, infectious disease, cancer diagnosis, protein quantification, and others. The infectious disease segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR of 8.43% in the market during the 2022-2030. ELISA is a powerful technique in immunology for detecting antibodies and antigens and performing allergy testing and autoimmune disease diagnosis. The growing incidence of autoimmune diseases, and viral diseases (HIV, STI, hepatitis B, and others) across the world owing to the aged population and changes in demographics and lifestyle is driving the growth of the global ELISA diagnostic testing market. As per the statistics given by National Stem Cell Foundation in 2023, autoimmune diseases affect more than 80 different types of diseases and nearly 4% of the world's population. The most common autoimmune diseases include type 1 diabetes, multiple sclerosis, rheumatoid arthritis, lupus, Crohn's disease, psoriasis, and scleroderma. In the United States, autoimmune diseases are the third most common cause of chronic illness. Although rare, collectively, these diseases affect between 5% and 8% of the US population. For instance, according to an article published by PubMed Central in May 2022, conventional serological detection of Autoimmune bullous disease (AIBD) specific antibodies involves an initial screening using tissue substrates, followed by an antigen-specific assay such as ELISA.

Moreover, various technological advancements, such as the development of next-generation immunodiagnostics platforms, are anticipated to drive the market growth.

Based on test type, is segregated as sandwich ELISA, indirect ELISA, competitive ELISA, and multiple & portable ELISA. The indirect ELISA segment held a larger market share in 2022 and the same segment is anticipated to register a higher CAGR during 2022-2030.

The ELISA diagnostic test market, by end user, is categorized as hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospital & diagnostic laboratories, and others. The hospital & diagnostic centers segment held the largest share of the market during 2020-2030.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the ELISA diagnostic test market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global ELISA diagnostic test market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global ELISA diagnostic test market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation
    • 1.2.1 Global ELISA Diagnostic Tests Market - by Adoption
    • 1.2.2 Global ELISA Diagnostic Tests Market - by Test Type
    • 1.2.3 Global ELISA Diagnostic Tests Market - by Application
    • 1.2.4 Global ELISA Diagnostic Tests Market - by End User
    • 1.2.5 Global ELISA Diagnostic Tests Market - by Region

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 ELISA Diagnostic Test Market, by Geography (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. ELISA Diagnostic Test Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 PEST Analysis

5. ELISA Diagnostic Test Market - Key Industry Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Rising Infectious Diseases Among Animals
    • 5.1.2 Increasing Incidence of Human Infections
  • 5.2 Key Market Restraints
    • 5.2.1 Incidents of Product Recalls
  • 5.3 Key Market Opportunities
    • 5.3.1 Innovative Product Launches
  • 5.4 Future Trends
    • 5.4.1 Advancements in ELISA-Based Procedures

6. ELISA Diagnostic Tests Market - Global Market Analysis

  • 6.1 ELISA Diagnostic Tests Market Revenue (US$ Mn), 2022 - 2030

7. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Adoption

  • 7.1 Overview
  • 7.2 ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • 7.3 Human
    • 7.3.1 Overview
    • 7.3.2 Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Veterinary
    • 7.4.1 Overview
    • 7.4.2 Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

8. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Test Type

  • 8.1 Overview
  • 8.2 ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 8.3 Sandwich ELISA
    • 8.3.1 Overview
    • 8.3.2 Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Indirect ELISA
    • 8.4.1 Overview
    • 8.4.2 Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Competitive ELISA
    • 8.5.1 Overview
    • 8.5.2 Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Multiple & Portable ELISA
    • 8.6.1 Overview
    • 8.6.2 Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

9. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by Application

  • 9.1 Overview
  • 9.2 ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • 9.3 Autoimmune Diseases
    • 9.3.1 Overview
    • 9.3.2 Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Infectious Disease
    • 9.4.1 Overview
    • 9.4.2 Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Cancer Diagnosis
    • 9.5.1 Overview
    • 9.5.2 Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Protein Quantification
    • 9.6.1 Overview
    • 9.6.2 Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.7 Others
    • 9.7.1 Overview
    • 9.7.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

10. Global ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals & Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Pharmaceutical & Biotechnology Companies
    • 10.4.1 Overview
    • 10.4.2 Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Veterinary Hospitals & Diagnostic Laboratories
    • 10.5.1 Overview
    • 10.5.2 Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)

11. ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 - Geographic Analysis

  • 11.1 North America: ELISA Diagnostic Tests Market
    • 11.1.1 Overview
    • 11.1.2 North America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.1.3 North America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.1.4 North America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.1.5 North America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.1.6 North America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.1.7 North America: ELISA Diagnostic Tests Market, by Country
      • 11.1.7.1 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.1 Overview
        • 11.1.7.1.2 US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.1.3 US: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.1.7.1.4 US: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.7.1.5 US: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.1.6 US: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.1 Overview
        • 11.1.7.2.2 Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.2.3 Canada: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.1.7.2.4 Canada: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.7.2.5 Canada: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.2.6 Canada: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.1.7.3 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.1 Overview
        • 11.1.7.3.2 Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.7.3.3 Mexico: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.1.7.3.4 Mexico: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.1.7.3.5 Mexico: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.1.7.3.6 Mexico: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.2 Europe: ELISA Diagnostic Tests Market
    • 11.2.1 Overview
    • 11.2.2 Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.2.3 Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.2.4 Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.2.5 Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.2.6 Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.2.7 Europe: ELISA Diagnostic Tests Market, by Country
      • 11.2.7.1 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.1 Overview
        • 11.2.7.1.2 Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.1.3 Germany: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.1.4 Germany: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.1.5 Germany: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.1.6 Germany: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.1 Overview
        • 11.2.7.2.2 France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.2.3 France: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.2.4 France: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.2.5 France: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.2.6 France: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.3 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.1 Overview
        • 11.2.7.3.2 UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.3.3 UK: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.3.4 UK: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.3.5 UK: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.3.6 UK: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.4 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.1 Overview
        • 11.2.7.4.2 Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.4.3 Italy: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.4.4 Italy: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.4.5 Italy: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.4.6 Italy: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.5 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.1 Overview
        • 11.2.7.5.2 Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.5.3 Spain: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.5.4 Spain: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.5.5 Spain: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.5.6 Spain: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.2.7.6 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.1 Overview
        • 11.2.7.6.2 Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.2.7.6.3 Rest of Europe: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.2.7.6.4 Rest of Europe: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.2.7.6.5 Rest of Europe: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.2.7.6.6 Rest of Europe: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.3 Asia Pacific: ELISA Diagnostic Tests Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.3.3 Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.3.4 Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.3.5 Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.3.6 Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.3.7 Asia Pacific: ELISA Diagnostic Tests Market, by Country
      • 11.3.7.1 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.1 Overview
        • 11.3.7.1.2 China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.1.3 China: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.1.4 China: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.1.5 China: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.1.6 China: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.1 Overview
        • 11.3.7.2.2 Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.2.3 Japan: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.2.4 Japan: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.2.5 Japan: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.2.6 Japan: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.3 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.1 Overview
        • 11.3.7.3.2 India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.3.3 India: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.3.4 India: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.3.5 India: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.3.6 India: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.4 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.1 Overview
        • 11.3.7.4.2 Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.4.3 Australia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.4.4 Australia: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
        • 11.3.7.4.5 Australia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.4.6 Australia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.5 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.1 Overview
        • 11.3.7.5.2 South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.5.3 South Korea: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.5.4 South Korea: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.5.5 South Korea: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.5.6 South Korea: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.3.7.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.1 Overview
        • 11.3.7.6.2 Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.3.7.6.3 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.3.7.6.4 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.3.7.6.5 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.3.7.6.6 Rest of Asia Pacific: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.4 Middle East & Africa: ELISA Diagnostic Tests Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.4.3 Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.4.4 Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.4.5 Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.4.6 Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.4.7 Middle East & Africa: ELISA Diagnostic Tests Market, by Country
      • 11.4.7.1 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.1 Overview
        • 11.4.7.1.2 South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.1.3 South Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.1.4 South Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.7.1.5 South Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.1.6 South Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.1 Overview
        • 11.4.7.2.2 Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.2.3 Saudi Arabia: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.2.4 Saudi Arabia: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.7.2.5 Saudi Arabia: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.2.6 Saudi Arabia: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.3 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.1 Overview
        • 11.4.7.3.2 UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.3.3 UAE: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.3.4 UAE: ELISA Diagnostic Tests Market, by Test Type , 2020-2030 (US$ Million)
        • 11.4.7.3.5 UAE: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.3.6 UAE: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.4.7.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.1 Overview
        • 11.4.7.4.2 Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.4.7.4.3 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.4.7.4.4 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.4.7.4.5 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.4.7.4.6 Rest of Middle East & Africa: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
  • 11.5 South & Central America: ELISA Diagnostic Tests Market
    • 11.5.1 Overview
    • 11.5.2 South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
    • 11.5.3 South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
    • 11.5.4 South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
    • 11.5.5 South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
    • 11.5.6 South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
    • 11.5.7 South & Central America: ELISA Diagnostic Tests Market, by Country
      • 11.5.7.1 Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.1 Overview
        • 11.5.7.1.2 Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.1.3 Brazil: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.5.7.1.4 Brazil: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.7.1.5 Brazil: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.1.6 Brazil: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.2 Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.1 Overview
        • 11.5.7.2.2 Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.2.3 Argentina: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.5.7.2.4 Argentina: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.7.2.5 Argentina: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.2.6 Argentina: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)
      • 11.5.7.3 Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.1 Overview
        • 11.5.7.3.2 Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.5.7.3.3 Rest of South & Central America: ELISA Diagnostic Tests Market, by Adoption, 2020-2030 (US$ Million)
        • 11.5.7.3.4 Rest of South & Central America: ELISA Diagnostic Tests Market, by Test Type, 2020-2030 (US$ Million)
        • 11.5.7.3.5 Rest of South & Central America: ELISA Diagnostic Tests Market, by Application, 2020-2030 (US$ Million)
        • 11.5.7.3.6 Rest of South & Central America: ELISA Diagnostic Tests Market, by End User, 2020-2030 (US$ Million)

12. ELISA Diagnostics Test Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in ELISA diagnostics test Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Bio-Rad Laboratories Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Idexx Laboratories Inc
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 F. Hoffmann-La Roche Ltd
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Thermo Fisher Scientific Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Abbott Laboratories
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Danaher Corp
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Innovative Diagnostics SAS
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Pictor Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 DiaSorin SpA
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Elabscience Biotechnology Inc
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Financial Overview
    • 13.10.4 SWOT Analysis
    • 13.10.5 Key Developments
  • 13.11 Bio-Techne Corp
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About Us
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. ELISA Diagnostic Test Market Segmentation
  • Table 2. SARS-CoV-2 Product Launches by Manufacturers Amid COVID-19 Pandemic
  • Table 3. North America US ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. North America US ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. North America ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. North America ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Following is a list of zoonotic disease outbreaks spread between animals and people.
  • Table 8. US ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. US ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. US ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. US ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. Canada ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. Canada ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. Canada ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. Canada ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. Mexico ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. Mexico ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. Mexico ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. Mexico ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Germany ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Germany ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Germany ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Germany ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. France ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. France ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. France ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. France ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. UK ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. UK ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. UK ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. UK ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Italy ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Italy ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Italy ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 39. Italy ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 40. Spain ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 41. Spain ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 42. Spain ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 43. Spain ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 44. Rest of Europe ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 45. Rest of Europe ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 46. Rest of Europe ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 47. Rest of Europe ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 48. Asia Pacific ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 49. Asia Pacific ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 50. Asia Pacific ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 51. Asia Pacific ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 52. China ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 53. China ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 54. China ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 55. China ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 56. Japan ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 57. Japan ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 58. Japan ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 59. Japan ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 60. India ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 61. India ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 62. India ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 63. India ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 64. Australia ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 65. Australia ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 66. Australia ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 67. Australia ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 68. South Korea ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 69. South Korea ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 70. South Korea ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 71. South Korea ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 72. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 73. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 74. Rest of Asia Pacific ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 75. Rest of Asia Pacific ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 76. Middle East & Africa ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 77. Middle East & Africa ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 78. Middle East & Africa ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 79. Middle East & Africa ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 80. South Africa ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 81. South Africa ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 82. South Africa ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 83. South Africa ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 84. Saudi Arabia ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 85. Saudi Arabia ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 86. Saudi Arabia ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 87. Saudi Arabia ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 88. UAE ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 89. UAE ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 90. UAE ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 91. UAE ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 92. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 93. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 94. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 95. Rest of Middle East & Africa ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 96. South & Central America ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 97. South & Central America ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 98. South & Central America ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 99. South & Central America ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 100. Brazil ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 101. Brazil ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 102. Brazil ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 103. Brazil ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 104. Argentina ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 105. Argentina ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 106. Argentina ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 107. Argentina ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 108. Rest of South & Central America ELISA Diagnostic Tests Market, by Adoption - Revenue and Forecast to 2030 (US$ Million)
  • Table 109. Rest of South & Central America ELISA Diagnostic Tests Market, by Test Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 110. Rest of South & Central America ELISA Diagnostic Tests Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 111. Rest of South & Central America ELISA Diagnostic Tests Market, by End User - Revenue and Forecast to 2030 (US$ Million)
  • Table 112. Recent Organic Growth Strategies in ELISA diagnostics Test Market
  • Table 113. Recent Inorganic Growth Strategies in the ELISA diagnostics Test Market
  • Table 114. Glossary of Terms, ELISA Diagnostic Tests Market

List Of Figures

  • Figure 1. ELISA Diagnostic Test Market Segmentation, By Geography
  • Figure 2. PEST Analysis
  • Figure 3. ELISA Diagnostic Test Market: Key Industry Dynamics
  • Figure 4. ELISA Diagnostic Tests Market: Impact Analysis of Drivers and Restraints
  • Figure 5. ELISA Diagnostic Tests Market Revenue (US$ Mn), 2021 - 2030
  • Figure 6. Global ELISA Diagnostic Tests Market, By Geography Forecast Analysis, 2022 & 2030
  • Figure 7. ELISA Diagnostic Tests Market Revenue Share, by Adoption 2022 & 2030 (%)
  • Figure 8. Human: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Veterinary: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. ELISA Diagnostic Tests Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 11. Sandwich ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Indirect ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Competitive ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Multiple & Portable ELISA: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. ELISA Diagnostic Tests Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 16. Autoimmune Diseases: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Infectious Disease: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Cancer Diagnosis: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Protein Quantification: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. ELISA Diagnostic Tests Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 22. Hospitals & Diagnostic Centers: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Pharmaceutical & Biotechnology Companies: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Veterinary Hospitals & Diagnostic Laboratories: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Others: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. North America: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 27. North America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. North America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 29. US: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Canada: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Mexico: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 33. Europe ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Europe: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 35. Germany: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. France: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. UK: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Italy: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Spain: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. Rest of Europe: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 41. Asia Pacific: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 42. Asia Pacific ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 43. Asia Pacific: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 44. China: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 45. Japan: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 46. India: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 47. Australia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 48. South Korea: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 49. Rest of Asia Pacific: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 50. Middle East & Africa: ELISA Diagnostic Tests Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 51. Middle East & Africa ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 52. Middle East & Africa: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 53. South Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 54. Saudi Arabia: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 55. UAE: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 56. Rest of Middle East & Africa: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 57. South & Central America: ELISA Diagnostic Tests Market, By Key Country - Revenue (2022) (US$ Million)
  • Figure 58. South & Central America ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 59. South & Central America: ELISA Diagnostic Tests Market, by Country, 2022 & 2030 (%)
  • Figure 60. Brazil: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 61. Argentina: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 62. Rest of South & Central America: ELISA Diagnostic Tests Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 63. Growth Strategies in ELISA diagnostics test Market